July 25, 2014 7:23 PM ET

Pharmaceuticals

Company Overview of Proacta, Inc.

Executive Profile

John Villiger Ph.D.

Chairman, Proacta, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 5 different industries.

See Board Relationships
60--

Background

Dr. John W. Villiger Ph.D. served as the Head of Product Development Worldwide, and Managing Director at The Medicines Company (NZ) Ltd., until April 2006. Dr. Villiger served as a Vice President of cardiovascular product development at Medicines Co., since March 1997, with a focus on cardiovascular product development. Dr. Villiger co-founded The Medicines Company, a Nasdaq listed company in 1996. Dr. Villiger served as Senior Vice President of Development of Medicines ...

Corporate Headquarters

4275 Executive Square
San Diego, California 92037

United States

Phone: 858-642-0386
Fax: 858-642-0653

Board Members Memberships

Former Director
Director
2004-Present
Chairman
2006-2013
Former Non Executive Director and Member of Remuneration & Nomination Committee

Education

PhD
University of Otago
PhD
University of Florida

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Proacta, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.